Literature DB >> 16104504

[Experimental study on MCF-7 cell apoptosis induced by ursolic acid].

Weiwen Zhang1, Yinyan Li, Guiping Zhang, Jiachun Lü, Huijian Ou.   

Abstract

OBJECTIVE: To study the effects of ursolic acid (UA), apentacyclic triterpene acid, on MCF-7 cell apoptosis.
METHODS: MCF-7 cells were cultured with different concentrations of UA. Viability of UA-induced MCF-7 cells was evaluated by MTT assay. Cell cycle and sub-G1 peak were performed by FCM. Morphologic changes of UA-treated cells were observed by light microscope. Apoptotic cells with condensed or fragmented nuclei were visualized by Ho33258 and PI staining by a fluorescence microscope (EX: U.V., Green light). p 53 protein expression was analyzed by fluorescence immunohistochemical method (SABC-Cy3). RESULT: 24 hours after UA treatment, inhibition of MCF-7 cell proliferation was concentration-dependent. The IC50 value for UA was 22.6 +/- 3.0 micromol/L. Cell cycle analysis by FCM showed that 50 micromol/L of the drug arrested MCF-7 cell cycle at G0-G1 phase. Morphological changes of MCF-7 cells exhibited many of the hallmark features of apoptosis, including condensation of chromatin and DNA fragmentation. UA increased p 53 protein expression.
CONCLUSION: The results suggest that UA evokes MCF-7 cell apoptosis is correlation with the up-regulation of p 53. The study indicated that UA might be a potential Chinese medical component for breast neoplasm.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16104504

Source DB:  PubMed          Journal:  Zhong Yao Cai        ISSN: 1001-4454


  2 in total

1.  Ursolic acid inhibits proliferation and induces apoptosis of cancer cells in vitro and in vivo.

Authors:  Xuemei Wang; Fan Zhang; Ling Yang; Ying Mei; Hai Long; Xiaowen Zhang; Jialing Zhang; Xiulan Su
Journal:  J Biomed Biotechnol       Date:  2011-05-30

2.  Therapeutic applications of herbal medicines for cancer patients.

Authors:  Shu-Yi Yin; Wen-Chi Wei; Feng-Yin Jian; Ning-Sun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2013-07-11       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.